Literature DB >> 22820553

GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain.

Florent Viguier1, Benoît Michot, Valérie Kayser, Jean-François Bernard, José-Miguel Vela, Michel Hamon, Sylvie Bourgoin.   

Abstract

Among receptors mediating serotonin actions in pain control, the 5-HT(7)R is of special interest because it is expressed by primary afferent fibers and intrinsic GABAergic and opioidergic interneurons within the spinal dorsal horn. Herein, we investigated whether GABA and/or opioids contribute to 5-HT(7)R-mediated control of neuropathic pain caused by nerve ligation. Acute administration of 5-HT(7)R agonists (AS-19, MSD-5a, E-55888) was found to markedly reduce mechanical and thermal hyperalgesia in rats with unilateral constriction injury to the sciatic nerve (CCI-SN). In contrast, mechanical hypersensitivity caused by unilateral constriction injury to the infraorbital nerve was essentially unaffected by these ligands. Further characterization of the anti-hyperalgesic effect of 5-HT(7)R activation by the selective agonist E-55888 showed that it was associated with a decrease in IL-1ß mRNA overexpression in ipsilateral L4-L6 dorsal root ganglia and lumbar dorsal horn in CCI-SN rats. In addition, E-55888 diminished CCI-SN-associated increase in c-Fos immunolabeling in superficial laminae of the lumbar dorsal horn and the locus coeruleus, but increased c-Fos immunolabeling in the nucleus tractus solitarius and the parabrachial area in both control and CCI-SN rats. When injected intrathecally (i.t.), bicuculline (3 μg i.t.), but neither phaclofen (5 μg i.t.) nor naloxone (10 μg i.t.), significantly reduced the anti-hyperalgesic effects of 5-HT(7)R activation (E-55888, 10 mg/kg s.c.) in CCI-SN rats. These data support the idea that 5-HT(7)R-mediated inhibitory control of neuropathic pain is underlain by excitation of GABAergic interneurons within the dorsal horn. In addition, 5-HT(7)R activation-induced c-Fos increase in the nucleus tractus solitarius and the parabrachial area suggests that supraspinal mechanisms might also be involved.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820553     DOI: 10.1016/j.neuropharm.2012.07.023

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

1.  Serotonin controls initiation of locomotion and afferent modulation of coordination via 5-HT7 receptors in adult rats.

Authors:  Anna M Cabaj; Henryk Majczyński; Erika Couto; Phillip F Gardiner; Katinka Stecina; Urszula Sławińska; Larry M Jordan
Journal:  J Physiol       Date:  2016-08-08       Impact factor: 5.182

2.  An investigation into the noradrenergic and serotonergic contributions of diffuse noxious inhibitory controls in a monoiodoacetate model of osteoarthritis.

Authors:  S M Lockwood; K Bannister; A H Dickenson
Journal:  J Neurophysiol       Date:  2018-11-21       Impact factor: 2.714

3.  5-HT7 Receptors Regulate Excitatory-Inhibitory Balance in Mouse Spinal Cord Dorsal Horn.

Authors:  Antonella Comitato; Enza Lacivita; Marcello Leopoldo; Rita Bardoni
Journal:  Front Mol Neurosci       Date:  2022-07-06       Impact factor: 6.261

4.  Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor.

Authors:  Xin Zhao; Chuang Wang; Jun-Fang Zhang; Li Liu; Ai-Ming Liu; Qing Ma; Wen-Hua Zhou; Ying Xu
Journal:  Psychopharmacology (Berl)       Date:  2013-12-03       Impact factor: 4.530

5.  Expression of the spinal 5-HT7 receptor and p-ERK pathway in the carrageenan inflammatory pain of rats.

Authors:  Soo Young Cho; Hyoung Gon Ki; Joung Min Kim; Jin Myung Oh; Ji Hoon Yang; Woong Mo Kim; Hyung Gon Lee; Myung Ha Yoon; Jeong Il Choi
Journal:  Korean J Anesthesiol       Date:  2015-03-30

Review 6.  Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date.

Authors:  Agnieszka Nikiforuk
Journal:  CNS Drugs       Date:  2015-04       Impact factor: 5.749

Review 7.  The development of descending serotonergic modulation of the spinal nociceptive network: a life span perspective.

Authors:  Anne R de Kort; Elbert A J Joosten; Jacob Patijn; Dick Tibboel; Nynke J van den Hoogen
Journal:  Pediatr Res       Date:  2021-07-13       Impact factor: 3.953

Review 8.  5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders.

Authors:  Lucia Ciranna; Maria Vincenza Catania
Journal:  Front Cell Neurosci       Date:  2014-08-27       Impact factor: 5.505

9.  Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: engagement of spinal serotonergic system.

Authors:  Xin Zhao; Chuang Wang; Wu-Geng Cui; Qing Ma; Wen-Hua Zhou
Journal:  Sci Rep       Date:  2015-03-12       Impact factor: 4.379

Review 10.  Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System.

Authors:  Jose Luis Cortes-Altamirano; Adriana Olmos-Hernandez; Herlinda Bonilla Jaime; Paul Carrillo-Mora; Cindy Bandala; Samuel Reyes-Long; Alfonso Alfaro-Rodríguez
Journal:  Curr Neuropharmacol       Date:  2018-01-30       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.